FEATURES

Opus Genetics Reports $7.5 Million Net Loss in Third Quarter

FARMINGTON HILLS, Mich.—Opus Genetics, Inc., a clinical-stage ophthalmic biotechnology company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and other ophthalmologic disorders, has announced financial results for the third quarter ended September 30, 2024.  Read more...


Sight Sciences Announces New Leadership Appointments

MENLO PARK, Calif.—Sight Sciences, Inc., an eyecare technology company, has announced the appointment of MK Raheja, PhD as its executive vice president, research and development, and Brenton Taylor as its executive vice president, operations, effective November 4, 2024.  Read more...


QLDS Names Gregory Walach as VP of Global Technical Support

LARGO, Fla.—Michael Walach, the president and founder of QLDS INC, a digital freeform lens design company, has announced the appointment of Gregory Walach to the position of vice president of global technical support.  Read more...


MOST READ STORIES

CURRENT
ISSUE

October 2024

October 2024

FEATURED COURSE

20/20 Pro to Pro Continuing Education